The unexpected alliance lobbying for Medicare to pay for new obesity drugs
Lawmakers banned coverage of obesity drugs when the Medicare’s prescription drug benefit was created in 2003.
Read The StoryBiotech
Inside the discoveries, personalities, and deals driving drug development. Sign up for The Readout newsletter to get the latest on biotech delivered to your inbox. And subscribe to STAT+ to access daily, market-moving coverage of the biotech sector — from startup funding to clinical trial readouts
Bay Area biotech uses AI to unlock RNA structures — and find new therapies in the process
Focused exclusively on life sciences, three top investors set out on their own
New results show Cassava’s Alzheimer’s drug has placebo-like efficacy
‘Holding on by its fingernails.’ The biotech industry in Massachusetts braces for another tough year
All Coverage
advertisement
